(Q38726032)
Statements
1 reference
The mTORC1/2 Inhibitor AZD8055 Strengthens the Efficiency of the MEK Inhibitor Trametinib to Reduce the Mcl-1/[Bim and Puma] ratio and to Sensitize Ovarian Carcinoma Cells to ABT-737. (English)
1 reference
Cécile Pétigny-Lechartier
1 reference
Charlène Duboc
1 reference
Abdelghani Jebahi
1 reference
Marie-Hélène Louis
1 reference
Edwige Abeilard
1 reference
Christophe Denoyelle
1 reference
Pascal Gauduchon
1 reference
Laurent Poulain
1 reference
Marie Villedieu
1 reference
15 December 2016
1 reference
1 reference
16
1 reference
1
1 reference
102-115
1 reference
Identifiers
1 reference
1 reference